Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

770 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effects of nefazodone on sleep architecture in depression.
Armitage R, Rush AJ, Trivedi M, Cain J, Roffwarg HP. Armitage R, et al. Among authors: rush aj. Neuropsychopharmacology. 1994 Apr;10(2):123-7. doi: 10.1038/npp.1994.14. Neuropsychopharmacology. 1994. PMID: 8024673
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients.
Rush AJ, Trivedi MH, Carmody TJ, Ibrahim HM, Markowitz JC, Keitner GI, Kornstein SG, Arnow B, Klein DN, Manber R, Dunner DL, Gelenberg AJ, Kocsis JH, Nemeroff CB, Fawcett J, Thase ME, Russell JM, Jody DN, Borian FE, Keller MB. Rush AJ, et al. Neuropsychopharmacology. 2005 Feb;30(2):405-16. doi: 10.1038/sj.npp.1300614. Neuropsychopharmacology. 2005. PMID: 15578008 Clinical Trial.
Report by the ACNP Task Force on response and remission in major depressive disorder.
Rush AJ, Kraemer HC, Sackeim HA, Fava M, Trivedi MH, Frank E, Ninan PT, Thase ME, Gelenberg AJ, Kupfer DJ, Regier DA, Rosenbaum JF, Ray O, Schatzberg AF; ACNP Task Force. Rush AJ, et al. Neuropsychopharmacology. 2006 Sep;31(9):1841-53. doi: 10.1038/sj.npp.1301131. Epub 2006 Jun 21. Neuropsychopharmacology. 2006. PMID: 16794566 Review.
What predicts attrition in second step medication treatments for depression?: a STAR*D Report.
Warden D, Rush AJ, Wisniewski SR, Lesser IM, Kornstein SG, Balasubramani GK, Thase ME, Preskorn SH, Nierenberg AA, Young EA, Shores-Wilson K, Trivedi MH. Warden D, et al. Among authors: rush aj. Int J Neuropsychopharmacol. 2009 May;12(4):459-73. doi: 10.1017/S1461145708009073. Epub 2008 Jul 9. Int J Neuropsychopharmacol. 2009. PMID: 18611293 Free PMC article. Clinical Trial.
Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.
Friedman ES, Davis LL, Zisook S, Wisniewski SR, Trivedi MH, Fava M, Rush AJ; CO-MED Study Team. Friedman ES, et al. Among authors: rush aj. Eur Neuropsychopharmacol. 2012 Mar;22(3):183-99. doi: 10.1016/j.euroneuro.2011.07.010. Epub 2011 Sep 14. Eur Neuropsychopharmacol. 2012. PMID: 21920711 Free PMC article. Clinical Trial.
Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: a CO-MED report.
Chan HN, Rush AJ, Nierenberg AA, Trivedi M, Wisniewski SR, Balasubramani GK, Friedman ES, Gaynes BN, Davis L, Morris D, Fava M. Chan HN, et al. Among authors: rush aj. Int J Neuropsychopharmacol. 2012 Nov;15(10):1387-99. doi: 10.1017/S1461145711001660. Epub 2011 Dec 1. Int J Neuropsychopharmacol. 2012. PMID: 22129562 Free article. Clinical Trial.
770 results